QC kit (4X10ML) - immunohematology reagents
Ended Purchase Order Awarded Last action
- Contract number
- W81K0024P0152
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $163,203
Award facts
- Opportunity
-
- Sources Sought Notice to provide Immunohematology Testing Reagents for the Brooke Army Medical Center (BAMC) Transfusion Services Section of the Department of Pathology and Area Laboratory Services (DPALS) Pre-Solicitation · W81K0024Q0066 · Posted Mar 21, 2024
- Contract value 39% obligated
-
- $249,658.08 Current, with exercised options
- $422,567.78 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | $86,455 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $76,748 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a firm fixed-price purchase order to Alba Bioscience, Inc. on October 1, 2024, with a ceiling value of $422,567.78 for QC kits (4X10ML) of immunohematology reagents. The award record carries a Total Small Business set-aside, although the originating pre-solicitation notice states no set-aside was used. Option Year 2 is extended under FAR 52.217-9 for October 1, 2026 through September 30, 2027, with an ultimate completion date of September 30, 2029. Performance is at 2330 Stanley Rd, Fort Sam Houston, TX 78234. The originating pre-solicitation, posted March 21, 2024 with responses due April 4, 2024, sought immunohematology reagents for the Brooke Army Medical Center Transfusion Services Section, including ABO typing, antigen typing, anti-human globulin, potentiator, and reagent red cell products, under NAICS 325413.
Quick answers
Who was awarded contract W81K0024P0152?
W81K0024P0152 was awarded to Alba Bioscience, Inc. by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0024P0152 worth?
The government has obligated $163,203 on W81K0024P0152. Its current value, with exercised options, is $249,658. Its potential value, with all options, is $422,568.
Which agency awarded contract W81K0024P0152?
Medical Command (Department of the Army) awarded W81K0024P0152, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0024P0152 competed?
The extent of competition for W81K0024P0152 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award